HOT NEWS
European Commission Issues Positive Decision for Approval of Seroquel XR » AstraZeneca announced that the European Commission (EC) has issued a positive decision for the appro...
Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC » Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from t...
Global market launch of Daxas® (Roflumilast) kicks off in Germany » Stefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas® ...
A new era for patients with atrial fibrillation - Dabigatran etexilate at the fo... » The European Society of Cardiology (ESC) issued revised practice guidelines for the management of at...
Genetic substudy shows fewer major cardiovascular events with ticagrelor (BRILIN... » A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that th...
Shire Announces European Approval of VPRIV® (velaglucerase alfa) » Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today...
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial ... » Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from...
GSK European Commission amends licence for Cervarix® » GlaxoSmithKline (GSK) confirmed that the European Commission has granted Marketing Authorisation to ...
Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial » Amgen (Nasdaq: AMGN) announced top-line results from a randomized Phase 3 trial evaluating Vectibix(...
Pfizer Reports Second-Quarter 2010 Results » Pfizer Inc. (NYSE: PFE) has reported financial results for second-quarter 2010. Since the acquisitio...
GlaxoSmithKline
GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel
Title Filter     Display # 
# Article Title Hits
1 GSK European Commission amends licence for Cervarix® 906
2 GSK receives CHMP positive opinion for a new indication for Arixtra 983
3 GSK EU regulatory update on Avandia (rosiglitazone) 920
4 GlaxoSmithKline enters agreement with Medivir for exclusive rights to cold sore treatment Xerclear™ 1008
5 GlaxoSmithKline receives conditional marketing authorisation in the EU for Arzerra® (ofatumumab) 965
6 Updated GlaxoSmithKline statement on European regulatory guidance relating to manufacture of Rotarix 902
7 GlaxoSmithKline announces Swiss approval of Duodart® 1250
8 GSK receives positive opinions in Europe for Tyverb® and Votrient™ 1263
9 Government orders for pandemic H1N1 vaccine 969
10 Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura 1437
11 GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib 1362
12 GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine 785
13 Experience of GSK's H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results 4408
14 Results from second clinical trial of GSK's H1N1 adjuvanted vaccine confirm immune response and tolerability 1663
15 GSK partners with UK Government and Wellcome Trust to stimulate innovation 1426
16 Initial results from first clinical trial of GSK's H1N1 adjuvanted vaccine 1013
17 Pandemic (H1N1) 2009 influenza update 857
18 Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis 1356
19 WHO grants prequalification to Cervarix®: GSK's vaccine to help combat cervical cancer in developing nations 1171
20 GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs 744
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share